Sangamo Therapeutics, Inc.
NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
Last updated:
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Status:
Application
Type:
Utility
Filling date:
15 Sep 2020
Issue date:
28 Jan 2021